Back to Journals » Drug Design, Development and Therapy » Volume 13

Subcutaneous bortezomib might be standard of care for patients with multiple myeloma: a systematic review and meta-analysis

Total article views   HTML views PDF downloads Totals
6,925 Dovepress* 6,244+ 1,163 7,407
PubMed Central* 681 237 918
Totals 6,925 1,400 8,325
*Since 16 May 2019

View citations on PubMed and Google Scholar